Related Experiment Video

Updated: May 18, 2026

A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro
07:03

A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro

Published on: June 16, 2022

A novel small molecule, NecroX-7, inhibits osteoclast differentiation by suppressing NF-κB activity and c-Fos

Hyun-Ju Kim1, Kyung-Ae Yoon, Mi-Kyung Lee

  • 1Skeletal Diseases Genome Research Center, Kyungpook National University and Hospital, Daegu 700-412, Republic of Korea. biohjk@hanmail.net

Life Sciences
|September 25, 2012
PubMed
Abstract

Insights

NecroX-7, a novel compound, effectively inhibits osteoclast formation and reduces bone loss by suppressing key signaling pathways. This suggests its potential as a therapeutic agent for bone resorption diseases like osteoporosis.

Area of Science:

  • Biochemistry
  • Immunology
  • Pharmacology

Background:

  • Osteoclasts are critical for bone resorption and implicated in diseases like osteoporosis and rheumatoid arthritis.
  • Targeting osteoclast formation presents a promising therapeutic strategy for bone-destructive conditions.
  • NecroX-7 is a novel small compound investigated for its effects on osteoclast biology.

Purpose of the Study:

  • To evaluate the impact of NecroX-7 on osteoclast differentiation and bone resorption.
  • To elucidate the molecular mechanisms underlying NecroX-7's effects on osteoclastogenesis.

Main Methods:

  • Assessed NecroX-7's effects on receptor activator of nuclear factor kappa B ligand (RANKL)-induced osteoclast differentiation in vitro.
  • Investigated NecroX-7's efficacy in inhibiting lipopolysaccharide (LPS)-induced bone loss in vivo.
  • Analyzed the modulation of key signaling pathways, including NF-κB and MAPKs, and transcription factors like c-Fos and NFATc1.

Main Results:

  • NecroX-7 dose-dependently suppressed osteoclast formation from bone marrow macrophages.
  • NecroX-7 inhibited the NF-κB signaling pathway but did not affect JNK, p38, or ERK MAPKs.
  • NecroX-7 attenuated the induction of c-Fos and NFATc1, leading to reduced expression of osteoclastogenic markers TRAP and cathepsin K.
  • NecroX-7 significantly inhibited LPS-induced bone loss in vivo.

Conclusions:

  • NecroX-7 demonstrates potent anti-osteoclastogenic activity both in vitro and in vivo.
  • The compound effectively suppresses critical signaling pathways and transcription factors essential for osteoclast differentiation.
  • NecroX-7 shows therapeutic potential for treating bone resorption-associated diseases.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes: